Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
An all-new interview with Scott Sand, CEO of Ingen Technologies, Inc. is also available on WallSt.net NEW YORK, Feb. 12 /PRNewswire/ -- The...
NEW YORK, Jan. 18 /PRNewswire/ -- The Analyst's Review is a daily podcast hosted by WallSt.net editor, Henry Truc that airs every morning at 9...
ADDITIONAL RESOURCES: Video, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/23534/consumer.html...
SOUTH SAN FRANCISCO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Genentech, Inc. today announced that it received a Complete Response Letter from...
SOUTH SAN FRANCISCO, Calif., Aug. 17 /PRNewswire-FirstCall/ -- The Genentech Foundation for Biomedical Sciences announced today that its Board...
CHICAGO, Dec. 7 /PRNewswire/ -- Seven Summits Research issues the following Morning Update at 8:30 AM EST with new PriceWatch Alerts for key...
Tiki Barber, Shaun Alexander and Others Join Merril Hoge and Dedicate 2005 Season to Raising Awareness of One of the Fastest Growing Cancers in...
Genentech Foundation for Biomedical Sciences Bolsters Innovation in Health Science Education With $1.2 Million for Bay Area Programs SOUTH SAN...
Preliminary Phase IIb Study Showed Rituxan Improved Symptoms in Rheumatoid Arthritis Patients Who Failed One or More Disease-Modifying Anti-Rheumat...
Addendum to Genentech Announces Fourth Quarter and Full Year 2004 Results (FINANCIAL TABLES) SOUTH SAN FRANCISCO, Calif., Jan. 10...
/FIRST AND FINAL ADD - SFW058 - GENENTECH ANNOUNCES THIRD QUARTER 2004 RESULTS/ GENENTECH, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS...
Genentech Receives Subpoena on Rituxan(R) SOUTH SAN FRANCISCO, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Genentech, Inc., has received a subpoena...
Genentech Foundation for Biomedical Sciences Awards More Than $1 Million to Science Education Programs in The Bay Area SOUTH SAN FRANCISCO...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지